Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Allotransplantation Stories

2013-10-22 20:21:02

#MHKnee takes viewers into the OR as surgeon repairs knee of sidelined athlete HOUSTON, Oct. 22, 2013 /PRNewswire/ -- In sports, ACL tears happen, and when star players like the Houston Texans' - then a University of Houston Cougar - Case Keenum, the Minnesota Vikings' Adrian Peterson and the Washington Redskins' Robert Griffin III suffer one, many fans and the public wonder: What is an ACL and how is it repaired? These questions will be answered tomorrow, October 23, when Houston's...

2013-10-11 16:24:09

Proceeds Split Nationally Between Make-A-Wish® and St. Jude Children's Research Hospital CARLSBAD, Calif., Oct. 11, 2013 /PRNewswire-iReach/ -- Spinal Elements www.spinalelements.com, an innovative spine technology company, officially celebrated the one-year anniversary of its "Hero Allograft" launch at this year's North American Spine Society (NASS) convention in New Orleans. The company hosted a celebration at the New Orleans House of Blues on Thursday, October 10th, where it...

2013-10-10 12:28:39

CARLSBAD, Calif., Oct. 10, 2013 /PRNewswire/ -- Advanced Biologics, developers and marketers of OsteoAMP® Allogeneic Morphogenetic Protein, announced today that it will be presenting new data and also showcasing a new graft delivery device at two of the larger, global orthopaedic meetings this week; the North American Spine Society (NASS) annual meeting in New Orleans, LA, and the Combined Meeting of Orthopaedic Research Societies (CORS) meeting in Venice, Italy. An abstract...

2013-10-10 08:29:48

CENTENNIAL, Colo. and RESEARCH TRIANGLE PARK, N.C., Oct. 10, 2013 /PRNewswire-USNewswire/ -- AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts and the world's largest processor of cellular bone allografts, and Humacyte, Inc., a pioneer in regenerative medicine pursuing development of investigational bioengineered blood vessels, announced today that they have entered into a long-term strategic manufacturing partnership. According to...

2013-10-01 08:30:26

MARIETTA, Ga., Oct. 1, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has entered into a distribution agreement with Medtronic, Inc. and SpinalGraft Technologies, LLC ("SGT"), a wholly-owned subsidiary of Medtronic. Through the agreement, MiMedx will provide its PURION® processed allograft products...

2013-09-26 18:06:07

Induced pluripotent stem cells (iPSCs) taken from a patient hold great therapeutic potential for many diseases. However, studies in rodents have suggested that the body may mount an immune response and destroy cells derived from iPSCs. New research in monkeys refutes these findings, suggesting that in primates like us, such cells will not be rejected by the immune system. In the paper, publishing September 26 in the ISSCR's journal Stem Cell Reports, published by Cell Press, iPSCs from...

2013-09-25 23:20:26

Reportbuyer.com just published a new market research report: Chinese Orthopedic Biomaterials Market. London (PRWEB) September 25, 2013 The Chinese orthopedic biomaterials market is expected to approach $522.3 million by 2019. The bone graft substitute segment is expected to constitute the majority of the Chinese orthopedic biomaterials market. The Chinese orthopedic biomaterials market comprises bone graft substitutes which is segmented into allografts, demineralized bone matrices (DBM)...

2013-09-25 16:25:23

MARIETTA, Ga., Sept. 25, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, commented today on various recent media reports concerning certain of the Company's tissue products and the amniotic tissue industry. While MiMedx's allografts have been in the market for over six years and over 170,000 units have been shipped, the...

2013-09-25 08:28:51

NEW YORK, Sept. 25, 2013 /PRNewswire/ -- ICAP Patent Brokerage announces for sale an innovative low inflammatory demineralized bone material - Allogeneic Bone Gel(TM) - for orthopedic applications from PlusLife® (formerly Perth Bone and Tissue Bank). PlusLife is a leading provider of high quality grafting materials for surgical treatment, and their novel demineralized bone material (DBM) has been cultivated through many years of research and studies. (Logo:...

2013-09-18 12:31:20

MARIETTA, Ga., Sept. 18, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has been selected to Georgia's 2013 Top 100 Public Companies. This prestigious list is sponsored by GeorgiaTrend Magazine and determined by S&P Capital IQ, a part of McGraw Hill Financial. The 2013 list is based on fiscal year...